ITOS: iTeos Therapeutics Inc Sotuvga nisbatan narx
iTeos Therapeutics (ITOS) yuqori o'sish potentsialiga ega bo'lgan ilg'or immuno-onkologiya segmentida faoliyat yuritadi. GURU.Markets grafigidagi narx/savdo ko'rsatkichi kotirovkalar va daromadlar orasidagi farqni kuzatishga yordam beradi, bunda 11.00 qiymati joriy raqamni ifodalaydi. Bozor kapitalizatsiyasi antitelalarni birgalikda ishlab chiqish uchun GSK dan keladigan to'lovlarga tayanadi, daromadlar esa tadqiqot bosqichlari uchun bonuslar va kelgusidagi royalti to'lovlariga asoslangan.
iTeos (ITOS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati iTeos Therapeutics|ITOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati iTeos Pharma|ITOS - Kompaniya qarzlari|Sof aktivlarga qarzlar iTeos|ITOS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari iTeos Therapeutics|Oraliq likvidlik koeffitsiyenti iteostherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
ITOS - Sof foyda|Kutilayotgan sof daromad iTeos Therapeutics|ITOS - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati iTeos Therapeutics Inc|ITOS - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati iTeos|ITOS - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) iTeos Therapeutics|ITOS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi iteostherapeutics.com|ITOS - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi iTeos Therapeutics
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning fundamental tahlili:ITOS, iteostherapeutics.com
iTeos Therapeutics (ITOS) kompaniyasining P/S tebranishlarini tahlil qilib, investor biznesning bozor qiymatini uning yillik aylanmasiga nisbatan baholaydi, bu esa kompaniyaning sanoat zarbalariga chidamliligini belgilaydi. Ushbu koeffitsient umumiy kapitalizatsiyani daromad bilan solishtiradi va mualliflik antibody immuno-onkologiya platformasi hamda B2B ishlanmalari patent doirasi sektor o'rtacha ko'rsatkichlariga nisbatan joriy bozor kutuvlarini qanchalik darajada oqlashini aks ettiradi.
iTeos Therapeutics kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti Protagonist Corp PTGX|IMVT (Immunovant, Inc.) - Kapitalizatsiyaning daromadga nisbati|KNSA: Kapitalizatsiyaning sotish hajmiga nisbati|GRFS (Grifols) - P/S multiplikatori|Sotuvga nisbatan narx Adaptive Biotech ADPT|Narxning daromadga nisbati Celldex (CLDX)|AUPH - Sotuvga nisbatan narx|Narxning daromadga nisbati BioCryst BCRX|Narx/daromad koeffitsiyenti veratx.com (VERA)|DNTH: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PHVS (Pharvaris NV)|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|TRML: Kapitalizatsiyaning sotish hajmiga nisbati|PGEN (Precigen, Inc.) - P/S multiplikatori|PHAR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NKTR|UPB - Sotuvga nisbatan narx|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Bozor kapitallashuvining daromadga nisbati IMNM|Gossamer Bio, Inc. - P/S multiplikatori|KALV - P/S multiplikatori|Septerna (SEPN) - Narxning daromadga nisbati|Narxning sotuvga nisbati PVLA (Pieris Pharma)|SVRA (Savara Corp) - P/S multiplikatori|Sotuvga nisbatan narx Rigel Corp RIGL|Kapitalizatsiyaning daromadga nisbati ANAB (AnaptysBio, Inc.)|P/S multiplikatori astriatx.com (ATXS)|enGene - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati RAPT (RAPT Therapeutics Inc.)|Aerovate - P/S multiplikatori|Narx/daromad koeffitsiyenti Aclaris Therapeutics, Inc ACRS|KYTX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati tizianalifesciences.com|Narxning daromadga nisbati Cabaletta Bio|Ventyx Biosciences Inc. (VTYX) - Narx/daromad koeffitsiyenti|P/S multiplikatori THTX|Narx/daromad koeffitsiyenti Avalo Therapeutics Inc|Eledon Pharmaceuticals - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati AGEN (agenusbio.com)|CLYM - Narxning daromadga nisbati|Sotuvga nisbatan narx Zura Bio Ltd|aTyr (ATYR) - Narxning daromadga nisbati|ADAG - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati ImageneBio|Shattuck Therapeutics - Narxning sotuvga nisbati|P/S multiplikatori EQ|CNTB (connectbiopharm.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori IMUX (Immunic)|P/S multiplikatori Atara Biotherapeutics, Inc. ATRA|IFRX - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati XFOR (x4pharma.com)|adicetbio.com (ACET) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Celularity|INMB (INmune Bio Corp) - P/S multiplikatori|P/S multiplikatori Barinthus Biotherapeutics Corp|Kapitalizatsiyaning daromadga nisbati KZR (Kezar Life Sciences)|SABS (sabbiotherapeutics.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori AKTX (Akari Therapeutics Plc)|Narx/daromad koeffitsiyenti Enlivex Therapeutics Ltd (ENLV)|QTTB - Narxning daromadga nisbati|GeoVax Corp (GOVX) - Kapitalizatsiyaning daromadga nisbati|Edesa Biotech, Inc. (EDSA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati ibioinc.com|Kapitalizatsiyaning daromadga nisbati CARM|P/S multiplikatori XTL Biopharmaceuticals Ltd|Narxning daromadga nisbati Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. (AIM) - Sotuvga nisbatan narx|Aditxt Corp - P/S multiplikatori|Narx/daromad koeffitsiyenti GRI Bio Inc GRI|XRTX (XORTX) - Kapitalizatsiyaning daromadga nisbati|HIND: Kapitalizatsiyaning sotish hajmiga nisbati|REVB (Revelation Biosciences) - P/S multiplikatori|Sotuvga nisbatan narx indaptusrx.com INDP|Narxning daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|CALI - Sotuvga nisbatan narx|Narxning daromadga nisbati Affimed N.V. AFMD|Narx/daromad koeffitsiyenti Allakos Inc (ALLK)|HOOK: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati IGMS (IGM Biosciences, Inc.)|OCEA (Ocean Biomedical) - Kapitalizatsiyaning daromadga nisbati|TCBP: Kapitalizatsiyaning sotish hajmiga nisbati|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
